• Journal Article

Clinical Outcomes of Crizotinib in Real-World Practice Settings for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer

Citation

Davis, K. L., Lenz, C., Houghton, K., & Kaye, J. A. (2017). Clinical Outcomes of Crizotinib in Real-World Practice Settings for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 98(1), 238-239. DOI: 10.1016/j.ijrobp.2017.01.168

Abstract